PP 2.4 - 00038 Age and biological sex but not sex hormones influence IL-15 biological activity by C. Stover, C. Levinger, M. Abongwa, A. Bosque

Connect to this object online.

PP 1.10 - 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir by J. Howard, C. Levinger, W. Wang, H. Takata, S. Nathanson, R. Fromentin, N. Chomont, L. Trautmann, A. Bosque

Connect to this object online.

Targeting STAT SUMOylation to enhance NK cell cytotoxicity by A. Macedo, C. Levinger, A.C. Hernandez Santini, N. Bonan, B. Nguyen, K. Crandall, R. Lynch, A. Bosque

Connect to this object online.

OP 5.2 - 00070 Characterization of a dual PTPN1/PTPN2 inhibitor to target latent HIV reservoirs by A. Bosque, J.N. Howard, T.D. Zaikos, C. Levinger, E. McMahon, H. Takata, E. Rivera, D.C. Copertino, W. Wang, M. Sanz-Perez, X. Arias-Moreno, N. Soriano-Sarabia, R. Brad Jones, L. Trautmann

Connect to this object online.

OP 2.7 - 00057 The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells by D.C. Copertino, C.S. Holmberg, A.R. Ward, J. Weiler, J.N. Howard, C. Levinger, A.P.S. Pang, M.J. Corley, F. Dündar, P. Zumbo, D. Betel, R.T. Gandhi, D.K. McMahon, R.J. Bosch, B.J. Macatangay, J.C. Cyktor, J.J. Eron, J.W. Mellors, A. Bosque, R. Brad Jones

Connect to this object online.